| | 
Part, Chapter, Paragraph
1 I, 2. 5 | working conditions (ILO, 2006).~ ~All these issues can
2 I, 2. 5 | rates. During the period 2006-2007 6.5 million new jobs
3 I, 2. 5 | will continue to grow. By 2006 it had reached the stage
4 I, 2. 5 | Safety and Health at Work, 2006).~Both case studies and
5 I, 2. 6 | Countries, per gender, in 2006.~ ~In the EU25 as a whole,
6 I, 2. 6 | points (European Commission, 2006).~While education is primarily
7 I, 2. 6 | level (European Commission, 2006).~ ~Considering the large
8 I, 2. 10. 2 | Royal Society, 2004; NIOSH, 2006; Schulte et al, 2007; Nel
9 I, 2. 10. 2 | et al, 2007; Nel et al, 2006; Medina et al, 2007).~ ~
10 I, 2. 10. 2 | uses include (Nel et al, 2006); (Medina et al, 2007).~ ~-
11 I, 2. 10. 3 | outsourcing internationally (ILO, 2006). Moreover, the speed with
12 I, 2. 10. 3(6) | International Labour Office (2006): Changing patterns in the
13 I, 2. 10. 3(6) | Conference, 95th Session 2006, Report I (C). ILO, Geneva.~
14 I, 2. 10. 3 | linking European Policies, 2006). From a business perspective,
15 I, 2. 10. 4(10)| 2005). Informe. Febrero 2006. Ministerio de Sanidad y
16 I, 2. 10. 4(10)| Sanidad y Consumo, Madrid 2006~
17 I, 2. 10. 4(11)| Ziekenhuizen, 10 November 2006~
18 I, 2. 10. 4 | Internet pharmacies. In 2006, 2.7 million items were
19 I, 2. 10. 4(13)| 275 – Revised 14 November 2006~
20 I, 2. 10. 4(14)| Results at the EU Border 2006”, European Commission, May
21 I, 2. 10. 4(15)| 275 – Revised 14 November 2006~
22 I, 2. 10. 4(20)| Confererence 13-15 June 2006, Minneapolis, Usa~
23 I, 2. 11 | Safety and Health at Work (2006). Research on New Forms
24 I, 2. 11 | 06).~European Commission (2006): European Economy. Directorate-general
25 I, 2. 11 | affairs. Special Report n° 1/2006. Available at: htt ~ ~European
26 I, 2. 11 | International Labour Office (2006): Changing patterns in the
27 I, 2. 11 | Conference, 95th Session 2006, Report I (C): ILO, Geneva~
28 I, 2. 11 | 552-558.~Nel A et al. (2006): Toxic potential of materials
29 I, 2. 11 | vol. 311, 622-627.~NIOSH (2006): NIOSH Safety and Health
30 I, 3. 2 | of the current EU27. In 2006, this percentage diminished
31 I, 3. 2 | Member States. From 1960 to 2006 the overall EU population
32 I, 3. 2 | Slovak Republic and Spain. In 2006, only Bulgaria had a lower
33 I, 3. 2 | Although, in the EU in the 1960-2006 period the entire yearly
34 I, 3. 2 | Compared to 2000, the 2006 population sizes were smaller
35 I, 3. 2 | per Member State in 1975, 2006 and forecasts for 2050~ ~
36 I, 3. 2 | will be 25% larger than 2006 in Cyprus, Ireland, Luxembourg,
37 I, 3. 3 | Age composition in EU27 in 2006~ ~Figure 3.5. Age composition
38 I, 3. 3 | composition in the NMS12 in 2006~ ~Currently, all European
39 II, 4. 1 | the GALI (van Oyen et al, 2006). The HLY is based on the
40 II, 4. 1 | Ministry of Health and Welfare, 2006).5~ ~ ~Table 4.1.5. Life
41 II, 4. 3 | Ministry of Health and Welfare (2006): Abridged Life Tables for
42 II, 4. 3 | Health and Human Services (2006): Healthy People 2010 Midcourse
43 II, 4. 3 | van der Heyden, et al. (2006): Monitoring population
44 II, 5. 2. 1 | Luxembourg – 1 and 2 June 2006; Allender et al, 2008) and
45 II, 5. 2. 1 | increased (Kesteloot et al, 2006). Despite the decline in
46 II, 5. 2. 2 | Kesteloot (Kesteloot et al, 2006). Trends over time have
47 II, 5. 2. 2 | 1997; Kesteloot et al, 2006). For the 27 EU member states
48 II, 5. 2. 3 | 1997; Kesteloot et al, 2006).~In the 35-74 age-range,
49 II, 5. 2. 5 | CVD risk (Palmieri et al, 2006; Giampaoli et al, 2006;
50 II, 5. 2. 5 | 2006; Giampaoli et al, 2006; Hozawa et al, 2007; Daviglus
51 II, 5. 2. 5 | non-communicable diseases.~· In 2006, a large conference organised
52 II, 5. 2. 5 | Council of the 30 November 2006 under the Finnish Presidency. (
53 II, 5. 2. 5 | November and 1 December 2006)~· The European Heart Health
54 II, 5. 2. 6 | incidence (Robinson JG et al, 2006). The ischemic stroke risk
55 II, 5. 2. 7 | Project Research Group (2006): EUROCISS Project final
56 II, 5. 2. 7 | report 2003 updated May 2006 [htt ] (accessed on 12.07.
57 II, 5. 2. 7 | European society of cardiology (2006): 2733 Employment, Social
58 II, 5. 2. 7 | Luxembourg – 1 and 2 June 2006. European Journal of Cardiovascular
59 II, 5. 2. 7 | Palmieri L, Panico S et al (2006): Favorable cardiovascular
60 II, 5. 2. 7 | Sans S, and Kromhout D (2006): Dynamics of cardiovascular
61 II, 5. 2. 7 | Sega R, and Stamler J (2006): Favorable cardiovascular
62 II, 5. 3. 1 | in EU25 as estimated in 2006.~ ~Table 5.3.1. Estimated
63 II, 5. 3. 1 | selected cancer sites in EU25 (2006).~ ~
64 II, 5. 3. 3 | European countries for the year 2006 (Ferlay et al, 2007).~-
65 II, 5. 3. 3 | also produced estimates in 2006 (Ferlay et al, 2007). The
66 II, 5. 3. 3 | published by EUROSTAT for 2006. The risk of cancer increases
67 II, 5. 3. 5 | cancer care performance. In 2006, 3,200,000 new cases and
68 II, 5. 3. 5 | highest incidence rates in 2006 were in Western Europe for
69 II, 5. 3. 5 | European standard) by sex in 2006 A) Men~Figure 5.3.1b. All
70 II, 5. 3. 5 | European standard) by sex in 2006 B) Women~ ~Figure 5.3.2a.
71 II, 5. 3. 5 | European standard) by sex in 2006 A) Men~Figure 5.3.3b. All
72 II, 5. 3. 5 | European standard) by sex in 2006 B) Women~ ~Figure 5.3.4a.
73 II, 5. 3. 5 | Stomach Cancer (ICD-9 151)~In 2006 Europe saw, 160,000 new
74 II, 5. 3. 5 | Ferlay et al, 2007). In 2006 maximum levels of incidence
75 II, 5. 3. 5 | European standard) by sex in 2006 A) Men~Figure 5.3.5b. Stomach
76 II, 5. 3. 5 | European standard) by sex in 2006 B) Women~ ~Figure 5.3.6a.
77 II, 5. 3. 5 | European standard) by sex in 2006 A) Men~Figure 5.3.7b. Stomach
78 II, 5. 3. 5 | European standard) by sex in 2006 B) Women~ ~Figure 5.3.8a.
79 II, 5. 3. 5 | Cancer (ICD-9 153, 154)~In 2006, 413,000 new cases and 207,
80 II, 5. 3. 5 | countries with a similar GDP. In 2006 Western Europe had maximum
81 II, 5. 3. 5 | European standard) by sex in 2006 A) Men~Figure 5.3.9b. Colorectal
82 II, 5. 3. 5 | European standard) by sex in 2006 B) Women~ ~Figure 5.3.10a.
83 II, 5. 3. 5 | European standard) by sex in 2006 A) Men~Figure 5.3.11b. Colorectal
84 II, 5. 3. 5 | European standard) by sex in 2006 B) Women~ ~Figure 5.3.12a.
85 II, 5. 3. 5 | Lung Cancer (ICD-9 162)~In 2006, in Europe there were 386,
86 II, 5. 3. 5 | countries with a similar GDP. In 2006 Iceland was the only country
87 II, 5. 3. 5 | macro-areas) for men in 2006 (92 new cases and 85 deaths
88 II, 5. 3. 5 | 27 deaths per 100,000 in 2006).~Most European countries
89 II, 5. 3. 5 | European standard) by sex in 2006 A) Men~Figure 5.3.13b. Lung
90 II, 5. 3. 5 | European standard) by sex in 2006 B) Women~ ~Figure 5.3.14a.
91 II, 5. 3. 5 | European standard) by sex in 2006 A) Men~Figure 5.3.15b. Lung
92 II, 5. 3. 5 | European standard) by sex in 2006 B) Women~ ~Figure 5.3.16a.
93 II, 5. 3. 5 | cases and 132,000 deaths in 2006 for the entire Europe (Ferlay
94 II, 5. 3. 5 | maximum incidence rate in 2006 was estimated in Belgium (
95 II, 5. 3. 5 | rates (European standard) in 2006~Figure 5.3.18. Trends of
96 II, 5. 3. 5 | rates (European standard) in 2006~Figure 5.3.20. Trends of
97 II, 5. 3. 5 | Prostate Cancer (ICD-9 185)~In 2006, 346,000 new cases and 87,
98 II, 5. 3. 5 | rates (European standard) in 2006~Figure 5.3.26. Trends of
99 II, 5. 3. 5 | rates (European standard) in 2006~Figure 5.3.28. Trends of
100 II, 5. 3. 7 | performed by ESMO (ESMO, 2006) underlined that in Europe:~·
101 II, 5. 3. 8 | published by the WHO in 2006)~· Diffusion of best practice:
102 II, 5. 3. 9 | suppl 5):v128-v149.~ ~ESMO (2006): Medical Oncology Status
103 II, 5. 3. 9 | and mortality in Europe in 2006. Ann Oncol 18(3):581-592.~ ~
104 II, 5. 3. 9 | on 9th June 2008).~ ~WHO (2006): The European Strategy
105 II, 5. 4. 1 | mmol/l. (Report WHO/IDF 2006). Two major subgroups of
106 II, 5. 4. 1 | third edition (IDF Atlas, 2006) reports 246 millions currently
107 II, 5. 4. 2 | Massi Benedetti et al. 2006) has played a role in proposing
108 II, 5. 4. 2 | in Europe (Carinci et al 2006).~In other cases, registers
109 II, 5. 4. 2 | HaemoglobinHbA1c, see Armesto et al. 2006) due to problems in national
110 II, 5. 4. 2 | striking with the IDF Atlas 2006, reporting a range between
111 II, 5. 4. 2 | the OECD (Armesto et al 2006) as fit for international
112 II, 5. 4. 3 | the field by the IDF Atlas 2006 and the core and secondary
113 II, 5. 4. 3 | According to the IDF data 2006, the absolute number of
114 II, 5. 4. 3 | approximately 31 million in 2006 to over 37 million in 2025.
115 II, 5. 4. 3 | over 37 million in 2025. In 2006, approximately 8.7% of the
116 II, 5. 4. 3 | tolerance. The IDF Atlas 2006 reports an average of 9%
117 II, 5. 4. 3 | OECD data (Armesto et al, 2006) show results for 7 EU countries
118 II, 5. 4. 6 | project was started in 2006 “to make the national facts
119 II, 5. 4. 6 | during its Presidency in 2006;~· the European Parliament,
120 II, 5. 4. 6 | European Parliament, in April 2006, urged the European Commission
121 II, 5. 4. 6 | organized in Vienna in February 2006, were adopted by the formal
122 II, 5. 4. 6 | formal Health Council in June 2006 as Diabetes EU policy;~·
123 II, 5. 4. 6 | Council of the European Union (2006) endorsed IDF recommendations,
124 II, 5. 4. 6 | in Luxembourg, 1-2 June 2006 (see Table 5.4.1);~ ~Table
125 II, 5. 4. 6 | health threat in December 2006 through the following statements (
126 II, 5. 4. 8 | the HCQI Expert GroupOECD (2006), 2006 Data Collection Update
127 II, 5. 4. 8 | Expert GroupOECD (2006), 2006 Data Collection Update Report,
128 II, 5. 4. 8 | Working Papers No. 29, OECD 2006~Azzopardi J, Fenech FF,
129 II, 5. 4. 8 | Council of the European Union (2006), Council Conclusions on
130 II, 5. 4. 8 | meeting, Luxembourg, 1-2 June 2006~[http://www.consilium.europa.
131 II, 5. 4. 8 | FEND, IDF European Region (2006):Diabetes: the Policy puzzle.
132 II, 5. 4. 8 | EU25 FEND /IDF - Europe 2006, available at: [http://www.
133 II, 5. 4. 8 | Technical Papers NO. 15~IDF (2006), Diabetes Atlas Third Edition.~
134 II, 5. 4. 8 | Carinci F, Orsini Federici M (2006), The Umbria Diabetes Register,
135 II, 5. 4. 8 | Register, Diab Res Clin Pract 2006; 74:S200-S204.~Morris AD,
136 II, 5. 4. 8 | IDF Consultation Report (2006): Definition and diagnosis
137 II, 5. 4. 8 | World Health Organization 2006 [http://www.who.int/entity/
138 II, 5. 5.Int(16)| International Longevity Center (2006): Ageism in America. New
139 II, 5. 5.Int(17)| Jamison DT, Murray CJL (2006): Global Burden of Disease
140 II, 5. 5.Int | consultation period ended in May 2006; in December 2006 the European
141 II, 5. 5.Int | in May 2006; in December 2006 the European Commission
142 II, 5. 5.Int(21)| covering the period 2002-2006, Decision N° 1513/2002/EC
143 II, 5. 5. 1 | physical illness (Saarni et al, 2006). In addition, depression
144 II, 5. 5. 1 | countries (Sobocki et al 2006). The total costs of depression
145 II, 5. 5. 1 | community level (Berk et al., 2006) and genetic factors (Currier
146 II, 5. 5. 1 | women committed suicide in 2006 (Eurostat). This number
147 II, 5. 5. 1 | beds ( Katschhnig ET AL., 2006).~ ~ WHO databases~ ~The
148 II, 5. 5. 1 | Berk M, Dodd S, Henry M (2006). The effect of macroeconomic
149 II, 5. 5. 1 | ESEMED/MHEDEA Investigators (2006). Risk factors for suicidality
150 II, 5. 5. 1 | International Longevity Center.(2006). Ageism in America. New
151 II, 5. 5. 1 | 17(1):14-9.~ ~S H et al. (2006). The impact of 29 chronic
152 II, 5. 5. 1 | Hogrefe and Huber.~ ~S C (2006). Cost of depression in
153 II, 5. 5. 2 | dementia (Alzheimer Scotland, 2006).~ ~Dementia tends to progress
154 II, 5. 5. 2 | Turkey (Alzheimer Europe, 2006). The results are as follows:~ ~
155 II, 5. 5. 2 | References~ ~Alzheimer Europe (2006): Dementia in Europe Yearbook.
156 II, 5. 5. 2 | Europe~ ~Alzheimer Scotland (2006): Good for you – good for
157 II, 5. 5. 3 | adolescents and females (Levey, 2006). Levey (2006) notes that
158 II, 5. 5. 3 | females (Levey, 2006). Levey (2006) notes that more than 90%
159 II, 5. 5. 3 | as in adulthood (Levey, 2006).~Anorexia as “appetite
160 II, 5. 5. 3 | 1002/eat.1022.~Levey R (2006): Anorexia Nervosa. eMedicine.
161 II, 5. 5. 3 | further evaluation (McGrath, 2006).~According to the fact
162 II, 5. 5. 3 | rate of diagnosis (Sato, 2006).~ ~The data concerning
163 II, 5. 5. 3 | study (Mathers and Loncar, 2006) describe a positive trend
164 II, 5. 5. 3 | other factors (Healy et al, 2006).~Currently available statistical
165 II, 5. 5. 3 | females (Mathers et al, 2006).~Deficits in social abilities
166 II, 5. 5. 3 | Punnoose and Belgamwar 2006).~The treatment of people
167 II, 5. 5. 3 | side effects (Engl et al, 2006) the increased rate in people
168 II, 5. 5. 3 | increased (Häfner and Maurer, 2006).~Effective intervention
169 II, 5. 5. 3 | of symptoms (Bottlender, 2006).~Although a number of prodromal
170 II, 5. 5. 3 | Pitschel-Walz, 2007; Vauth, 2006,; Glynn, 2003; Pilling et
171 II, 5. 5. 3 | development process (Leucht et al, 2006; Gaebel et al, 2005; AGREE
172 II, 5. 5. 3 | renaming schizophrenia (Sato, 2006). A pilot study recently
173 II, 5. 5. 3 | thereby save costs” (Leucht, 2006).~Fighting stigma~Some countries
174 II, 5. 5. 3 | of print.~Bottlender R (2006): For and against: “Every
175 II, 5. 5. 3 | CP, Jones L, Woolson RF (2006): Medical comorbidity in
176 II, 5. 5. 3 | Parsch JR, Ebenbichler C (2006): Antipsychotic drug-induced
177 II, 5. 5. 3 | 2007.~European Commission (2006): Report and Recommendations
178 II, 5. 5. 3 | Häfner H and Maurer K (2006): Early detection of schizophrenia:
179 II, 5. 5. 3 | Jones-Edwards G, Roberts AP (2006): Lifetime suicide rates
180 II, 5. 5. 3 | Wahlbeck K, Kissling W (2006): Call for a European guidelines
181 II, 5. 5. 3 | 1991.~Mathers CD, Loncar D (2006): Projections of Global
182 II, 5. 5. 3 | 3(11):e442.~McGrath JJ (2006): Variations in the incidence
183 II, 5. 5. 3 | Punnoose S, Belgamwar MR (2006): Nicotine for schizophrenia.
184 II, 5. 5. 3 | 370(9590):810-11.~Sato M (2006): Renaming schizophrenia:
185 II, 5. 5. 3 | 333, 2007.~htt df~Vauth R (2006): Psychosocial Interventions
186 II, 5. 5. 3 | Finally, at the beginning of 2006 the EAIS project approved
187 II, 5. 5. 3 | 2002; Pugliatti et al, 2006; Pugliatti and Rosati, in
188 II, 5. 5. 3 | elsewhere (Pugliatti et al, 2006).~When feasible, the total
189 II, 5. 5. 3 | patients in Norway (Myhr et al, 2006; www ). In 2007, a biobank
190 II, 5. 5. 3 | Sweden (Brønnum-Hansen et al, 2006) probably indicating a similar
191 II, 5. 5. 3 | and 127 (Pugliatti et al, 2006) and an estimated mean annual
192 II, 5. 5. 3 | Cyprus (Pugliatti et al, 2006), with a mean annual incidence
193 II, 5. 5. 3 | Portugal (Pugliatti et al, 2006), increasing trends in Norway,
194 II, 5. 5. 3 | programmes (Miller et al, 2006). Also, home-based care
195 II, 5. 5. 3 | of the original report 2006 (MSTCG and Rieckmann, 2006)~
196 II, 5. 5. 3 | 2006 (MSTCG and Rieckmann, 2006)~Recent clinical studies
197 II, 5. 5. 3 | Therapie bei MS”. (Henze et al, 2006).~Although there is a vast
198 II, 5. 5. 3 | sclerosis ( Haffenden et al, 2006).~This position paper based
199 II, 5. 5. 3 | Hansen T, Koch-Henriksen H (2006): Survival and mortality
200 II, 5. 5. 3 | Paulos A, Mendes H, et al (2006): The prevalence of multiple
201 II, 5. 5. 3 | the extension phase 2005/2006. Poster presentation at
202 II, 5. 5. 3 | Glad SB, Aarseth JH, et al (2006): A 50-year follow-up of
203 II, 5. 5. 3 | Pitschnau-Michel D, Voltz D (2006) Position Paper Palliative
204 II, 5. 5. 3 | Rieckman, P and Toyka KY (2006): Symptomatic Treatment
205 II, 5. 5. 3 | Sclerosis Society. Eur Neurol. 2006;56(2):78-105~Horakova D (
206 II, 5. 5. 3 | Noseworthy J, Compston A (2006): Care of the person with
207 II, 5. 5. 3 | group) and Rieckmann P (2006): Escalating immunomodulatory
208 II, 5. 5. 3 | N, Aarseth JH, Nyland H (2006): The Norwegian Multiple
209 II, 5. 5. 3 | Ristic S, Sepcic J, et al (2006): Region with persistent
210 II, 5. 5. 3 | Rosati G, Carton H, et al (2006): The epidemiology of multiple
211 II, 5. 5. 3 | disability (Horstink et al, 2006). This considerably affects
212 II, 5. 5. 3 | al, 2005; Dowding et al, 2006; Lindgren et al, 2005; von
213 II, 5. 5. 3 | implicated (Chade et al, 2006). Fall et al (1999) found
214 II, 5. 5. 3 | Quik, 2004; Chade et al 2006). However, whether this
215 II, 5. 5. 3 | AR, Kasten M, Tanner CM (2006): Nongenetic causes of Parkinson’
216 II, 5. 5. 3 | CH, Shenton CL, Salek SS (2006): A review of the health-related
217 II, 5. 5. 3 | W, Rascol O, Sampaio C (2006): Review of the therapeutic
218 II, 5. 6. 1 | European Strategy for NCD 2006).~ ~
219 II, 5. 6. 3 | European Strategy for NCD 2006) and osteoarthritis is the
220 II, 5. 6. 3 | countries (Lopez et al, 2006).~ ~Health care utilization~ ~
221 II, 5. 6. 3 | burden and risk factors 2006) .~ ~Economic impact is
222 II, 5. 6. 3 | mortality (Woolf and Akesson, 2006).~ ~Colle’s fracture results
223 II, 5. 6. 6 | Department of Health, UK (2006): The Musculoskeletal Services
224 II, 5. 6. 6 | Jamison DT, Murray CJL (2006): Global Burden of Disease
225 II, 5. 6. 6 | URL : ht ~ ~WHO Europe (2006): Gaining Health. The European
226 II, 5. 6. 6 | Copenhagen, 11-14 September 2006. Available at URL: htt ~ ~
227 II, 5. 6. 6 | Woolf AD and Akesson K (2006): The Patient with Osteoporosis.
228 II, 5. 7. 1 | al. 2006b; Cirillo et al, 2006; Van Biesen et al, 2007);
229 II, 5. 7. 1 | Kidney Foundation, 2002-2006; Sarnak et al., 2003; American
230 II, 5. 7. 1 | American Diabetes Association, 2006), but this knowledge has
231 II, 5. 7. 1 | 2005; Kimmel and Patel, 2006) and in children (McKenna
232 II, 5. 7. 1 | children (McKenna et al, 2006; Fadrowski et al, 2006),
233 II, 5. 7. 1 | 2006; Fadrowski et al, 2006), these diseases impose
234 II, 5. 7. 3 | al, 2004; Stewart et al, 2006). The increasing incidence
235 II, 5. 7. 3 | Norway) (Hallan et al, 2006) to 7.2% (Germany) (Meisinger
236 II, 5. 7. 3 | Germany) (Meisinger et al, 2006) in males and from 6.2% (
237 II, 5. 7. 3 | Italy) (Cirillo et al, 2006) to 10.2% (Iceland) (Viktorsdottir
238 II, 5. 7. 3 | Norway (Hallan et al, 2006; Hallan et al, 2006). In
239 II, 5. 7. 3 | al, 2006; Hallan et al, 2006). In all countries where
240 II, 5. 7. 3 | NHANES IV) (Tonelli et al, 2006; Zoccali and DeJong, 2007),
241 II, 5. 7. 3 | al, 2004; Stewart et al, 2006). The increasing incidence
242 II, 5. 7. 4 | obesity (Ejerblad et al, 2006) and perhaps non-traditional
243 II, 5. 7. 4 | oxide synthase (Zoccali 2006) appear to be the main drivers
244 II, 5. 7. 4 | in children (Wang et al, 2006). Since these risk factors
245 II, 5. 7. 5 | 2003; Atthobari et al, 2006). Targeting individuals
246 II, 5. 7. 5 | 92 dialysis centres; in 2006, there were 464 pmp under
247 II, 5. 7. 7 | Diabetes Association (ADA) (2006): Standards of medical care
248 II, 5. 7. 7 | diabetes-2006. Diabetes Care 2006;29:S1-S85.~Annual data report
249 II, 5. 7. 7 | HL, van Gilst WH, et al (2006): Cost-effectiveness of
250 II, 5. 7. 7 | studies. Clin Therapeutics, 2006;28:432-44.~Baigent C, Burbury
251 II, 5. 7. 7 | Lombardi C, De Santo NG (2006): Low glomerular filtration
252 II, 5. 7. 7 | and awareness. Kidney Int 2006 Aug;70(4):800-6.~Coresh
253 II, 5. 7. 7 | McLaughlin JK, Nyren O (2006): Obesity and risk for chronic
254 II, 5. 7. 7 | failure. J Am Soc Nephrol 2006 Jun;17(6):1695-702.~ERA-EDTA
255 II, 5. 7. 7 | Weiss RA, Gerson A, et al (2006): Changes in physical and
256 II, 5. 7. 7 | disease. Pediatr Nephrol 2006 Mar;21(3):394-9.~Gansevoort
257 II, 5. 7. 7 | ESRD risk. J Am Soc Nephrol 2006; 17:2275-84.~Hallan SI,
258 II, 5. 7. 7 | sectional health survey. BMJ 2006 Nov 18;333(7577):1047.~Hsu
259 II, 5. 7. 7 | 20.~Kimmel PL, Patel SS (2006): Quality of life in patients
260 II, 5. 7. 7 | hemodialysis. Semin Nephrol 2006 Jan;26(1):68-79.~Kurella
261 II, 5. 7. 7 | S, Williams A, Geary DF (2006): Quality of life in children
262 II, 5. 7. 7 | Nephrol Dial Transplant 2006 Jul;21(7):1899-905.~Meisinger
263 II, 5. 7. 7 | Meisinger C, Doring A, Lowel H (2006): Chronic kidney disease
264 II, 5. 7. 7 | population. Eur Heart J 2006 May;27(10):1245-50.~National
265 II, 5. 7. 7 | disease. Am J Kidney Dis 2006;47(Suppl 3):S1-S145.~National
266 II, 5. 7. 7 | McCredie MR, Williams SM (2006): Geographic, ethnic, age-related
267 II, 5. 7. 7 | Nephrol Dial Transplant 2006 Aug;21(8):2178-83.~Tonelli
268 II, 5. 7. 7 | Rabbat C, Fok M, et al (2006): Chronic kidney disease
269 II, 5. 7. 7 | review. J Am Soc Nephrol 2006 Jul;17(7):2034-47.~ ~
270 II, 5. 8. 1 | UE-25 (Niederlander et al, 2006). COPD is the main reason
271 II, 5. 8. 1 | and emphysema: (Siafakas, 2006). COPD has significant extra-pulmonary
272 II, 5. 8. 1 | particles or gases (GOLD, 2006).~ ~Exposure to noxious
273 II, 5. 8. 3 | criteria (Lindberg et al 2006). This was significantly
274 II, 5. 8. 3 | never-smokers (Pelkonen et al, 2006).~ ~In another study performed
275 II, 5. 8. 3 | for 25 years (Lokke et al, 2006). Abnormal lung function
276 II, 5. 8. 3 | published (Chapman et al, 2006). The variability of prevalence
277 II, 5. 8. 3 | meta-analysis (Halbert et al, 2006) estimated a prevalence
278 II, 5. 8. 3 | and 0.3% (Zielinski et al, 2006). People with chronic cough
279 II, 5. 8. 3 | severe 0.1%) (Lindberg et al 2006). All subjects with severe
280 II, 5. 8. 3 | declined (Chapman et al, 2006).~ ~Interesting data are
281 II, 5. 8. 3 | COPD (Rea et al 2004; GOLD 2006)~ ~A relevant association
282 II, 5. 8. 3 | underlying causes (Furhman et al, 2006). In this study, cardiovascular
283 II, 5. 8. 3 | by Calverley and Scott (2006). The authors stated that,
284 II, 5. 8. 3 | Netherlands (Vermeeren et al, 2006). The results showed that
285 II, 5. 8. 3 | 10% (Carrasco Garrido, 2006). In a study by Sprenkle
286 II, 5. 8. 3 | compared (Chapman et al 2006). It was shown that the
287 II, 5. 8. 3 | of Dubrovnik during 2002-2006. COPD patients (446) were
288 II, 5. 8. 4 | never-smokers (Pelkonen et al, 2006). During the follow-up,
289 II, 5. 8. 4 | for 25 years (Lokke et al, 2006). Abnormal lung function
290 II, 5. 8. 5 | panbronchiolitis (Siafakas et al, 2006). For this reason, chest
291 II, 5. 8. 5 | every year by GOLD (GOLD, 2006).~ ~The Global Alliance
292 II, 5. 8. 7 | Calverley PMA, Scott S. (2006): Is Airway Inflammation
293 II, 5. 8. 7 | Obstructive Pulmonary Disease 2006; 3: 233-242~ ~Celli BR,
294 II, 5. 8. 7 | 242~ ~Celli BR, MacNee W (2006): ATS/ERS Task Force Standards
295 II, 5. 8. 7 | Aldington S, Beasley R (2006): Epidemiology and costs
296 II, 5. 8. 7 | pulmonary disease. Eur Respir J 2006; 27: 188-207.~ ~Dal Negro
297 II, 5. 8. 7 | Eilstein D, Delmas M-C (2006): Deaths from chronic obstructive
298 II, 5. 8. 7 | multiple cause analysis. Thorax 2006; 61: 930-934.~ ~Geijer RM,
299 II, 5. 8. 7 | Med 102:885-891~ ~GOLD (2006): Global Strategy for the
300 II, 5. 8. 7 | Executive Summary, updated 2006. The Global initiative for
301 II, 5. 8. 7 | co-morbidity. Respir Res 2006; 7: 109-116.~ ~Halbert RJ,
302 II, 5. 8. 7 | E, Buist AS, Mannino DM (2006):Global burden of COPD:
303 II, 5. 8. 7 | meta-analysis. Eur Respir J 2006; 28: 523-532.~ ~Hansell
304 II, 5. 8. 7 | Larsson LG, Lundback B. (2006): Prevalence and underdiagnosis
305 II, 5. 8. 7 | Sweden Studies. Respir Med 2006; 100: 264-272.~ ~Lindberg
306 II, 5. 8. 7 | Sandstrom T, Lundback B (2006): Seven-year cumulative
307 II, 5. 8. 7 | population sample. Chest 2006; 129: 879-885.~ ~Lokke A,
308 II, 5. 8. 7 | Fabricius P, Vestbo J (2006): Developing COPD: a 25
309 II, 5. 8. 7 | general population. Thorax 2006; 61: 935-939.~ ~L J (2006):
310 II, 5. 8. 7 | 2006; 61: 935-939.~ ~L J (2006): Global and regional burden
311 II, 5. 8. 7 | population health data. Lancet 2006; 367: 1747-1757.~ ~Lundback
312 II, 5. 8. 7 | Martin A, Alvarez-Sala JL (2006): Chronic respiratory symptoms,
313 II, 5. 8. 7 | general population. Respir Med 2006; 100: 1973-1980.~ ~Mohangoo
314 II, 5. 8. 7 | Schellevis FG, Raat H (2006): Prevalence estimates of
315 II, 5. 8. 7 | difference? Eur J Public Health 2006; 16: 101-105.~ ~Murray CJ,
316 II, 5. 8. 7 | Niederlander E. Health (2006): In “Population and social
317 II, 5. 8. 7 | and social conditions”, 10/2006, Eurostat.~ ~Pelkonen M,
318 II, 5. 8. 7 | Tukiainen H, Koskela H (2006): Thirty-year cumulative
319 II, 5. 8. 7 | middle-aged rural men. Chest 2006; 130: 1129-1137.~ ~Rea H,
320 II, 5. 8. 7 | Respir Mon, Monograph 38, 2006; 11: 1-6.~ ~Sidney S, Sorel
321 II, 5. 8. 7 | Roldaan AC, Wouters EF (2006):on behalf of the COSMIC
322 II, 5. 8. 7 | patients with COPD. Respir Med 2006; 100: 1349-1355.~ ~Viegi
323 II, 5. 8. 7 | awareness. Eur Respir J 2006; 27: 833-852.~ ~Zock J-P,
324 II, 5. 9. 1 | symptoms (Holgate et al, 2006).~ ~Allergic rhinitis (AR)
325 II, 5. 9. 1 | increase (Holgate et al, 2006). Changes in diagnostic
326 II, 5. 9. 1 | daily life (Baiardini et al, 2006).~ ~Understanding asthmatic
327 II, 5. 9. 3 | of Dubrovnik during 2002-2006. Asthma patients (4121)
328 II, 5. 9. 4 | PARSIFAL study (Alf T et al, 2006). Growing up on a farm was
329 II, 5. 9. 4 | contact eczema) from 2003 to 2006 in a population-based sample
330 II, 5. 9. 4 | bioassays.(Steerenberg PA 2006)~Fine ambient PM exerted
331 II, 5. 9. 4 | Hygiene Hypothesis” (Wang, 2006; von Mutius, 2006; Heinrich
332 II, 5. 9. 4 | Wang, 2006; von Mutius, 2006; Heinrich et al, 2001).~ ~
333 II, 5. 9. 6 | of view (Baiardini et al, 2006). HRQoL is assessed by means
334 II, 5. 9. 6 | Asthma (GINA) document (GINA, 2006). Global strategy for asthma
335 II, 5. 9. 6 | Respiratory Diseases (GARD) (Bo l, 2006), a WHO initiative aiming
336 II, 5. 9. 6 | recommendations (Bousquet et al, 2006). ARIA goals for both specialists
337 II, 5. 9. 7 | References~ ~Alfvén T (2006): Allergic diseases and
338 II, 5. 9. 7 | PARSIFAL study. Allergy. 2006 Apr;61(4):414-21.~ ~Anderson
339 II, 5. 9. 7 | Brandi S, Canonica GW (2006): Allergic diseases and
340 II, 5. 9. 7 | Allergy Asthma Immunol. 2006; 97:419-28~ ~Barnes PJ, Jon B (
341 II, 5. 9. 7 | of asthma. Eur Respir J. 2006 Apr;9(4):636-42~ ~Bj P (
342 II, 5. 9. 7 | Rev 2003; 3:43-45~ ~Bo N (2006): GARD (Global Alliance
343 II, 5. 9. 7 | Initiative for Asthma (GINA) (2006): Global strategy for asthma
344 II, 5. 9. 7 | and prevention. Revised 2006~ ~Masoli M, Fabian D, Holt
345 II, 5. 9. 7 | ST, Price D, Valovirta E (2006): Asthma out of control?
346 II, 5. 9. 7 | BMC Pulmonary Medicine 2006, 6(Suppl 1):S2 doi:10.1186/
347 II, 5. 9. 7 | 116:675-682).~ ~Keil T (2006): European birth cohort
348 II, 5. 9. 7 | GA2LEN initiative. Allergy 2006;61:221-228~ ~Kim DS, Drake-Lee
349 II, 5. 9. 7 | 6):1232-8~ ~von Mutius (2006): The PASTURE project: EU
350 II, 5. 9. 7 | atopy in Europe. Allergy 2006;61:407-413~ ~Vrbica Ž (2007):
351 II, 5. 9. 7 | hr~ ~Wang Y, McCusker C (2006): Neonatal exposure with
352 II, 5. 9. 7 | J Allergy Clin Immunol. 2006 Jul;118(1):143-51. Epub
353 II, 5. 9. 7 | Jul;118(1):143-51. Epub 2006 May 19.~ ~World Health Organization (
354 II, 5. 10. 1 | EFSA, 2004 and INFOSAN, 2006)~ ~ ~ ~Up to 18% of the
355 II, 5. 10. 1 | The InformALL database, 2006), although few foods are
356 II, 5. 10. 2 | al, 2003; Gendel et al, 2006). The design, structure,
357 II, 5. 10. 2 | age-dependant (DunnGalvin A, 2006). In addition, most of the
358 II, 5. 10. 6 | modified organisms, Taylor, 2006; Thomas et al, 2007).~ ~
359 II, 5. 10. 7 | Elberink JNG, Klinge I (2006): Incorporating a gender
360 II, 5. 10. 7 | Gendel SM, Jenkins JA (2006): Allergen sequence databases.
361 II, 5. 10. 7 | Authorities Network (INFOSAN) (2006): INFOSAN information note
362 II, 5. 10. 7 | INFOSAN information note No. 3/2006- Food Allergies. World Health
363 II, 5. 10. 7 | Health Organization, 9 June 2006. htt ~ ~Knibb RC, Booth
364 II, 5. 10. 7 | Allergy 56: 91-102.~Tay L (2006): Review of the development
365 II, 5. 11. 3 | dermatologic care (Williams et al, 2006).~ ~Skin diseases are a
366 II, 5. 11. 3 | in Europe Eur J Dermatol 2006;16:212-218~ ~ ~Table 5.11.
367 II, 5. 11. 7 | Grob JJ, Bouwes Bavick JN (2006): Epidemiology of skin diseases
368 II, 5. 11. 7 | in Europe Eur J Dermatol 2006:16:212-218.~ ~ ~ ~
369 II, 5. 12. 1 | Scotland (Leon and McCambridge, 2006).~In order to monitor recent
370 II, 5. 12. 4 | populations (Leon and McCambridge, 2006). Although there are suggestions
371 II, 5. 12. 7 | Leon DA, McCambridge J (2006): Liver cirrhosis mortality
372 II, 5. 15. 3 | et al, 2007; Dear et al, 2006; Kesselman et al, 2006;
373 II, 5. 15. 3 | 2006; Kesselman et al, 2006; Aronson, 2006; Haffner,
374 II, 5. 15. 3 | Kesselman et al, 2006; Aronson, 2006; Haffner, 2006; Clarke,
375 II, 5. 15. 3 | Aronson, 2006; Haffner, 2006; Clarke, 2006; McCabe, 2005).
376 II, 5. 15. 3 | Haffner, 2006; Clarke, 2006; McCabe, 2005). Currently
377 II, 5. 15. 4 | collected was published in 2006 (European Commission, 2006).
378 II, 5. 15. 4 | 2006 (European Commission, 2006). This second publication
379 II, 5. 15. 4 | Demonstration Activities (2002-2006) has included among its
380 II, 5. 15. 6 | 18.04.2008).~Clarke JT (2006): Is the current approach
381 II, 5. 15. 6 | drug review policy. CMAJ. 2006 Jan 17;174(2):189-90.~Dear
382 II, 5. 15. 6 | Lilitkarntakul P, Webb DJ (2006): Are rare diseases still
383 II, 5. 15. 6 | products. Br J Clin Pharmacol 2006, 62:3, 264-271.~Drummond
384 II, 5. 15. 6 | 42~European Commission (2006): Inventory of Community
385 II, 5. 15. 6 | 12.05.2007)~Haffner ME (2006): Adopting orphan drugs --
386 II, 5. 15. 6 | rare diseases. N Engl J Med. 2006 Feb 2;354(5):445-7.~Holzman
387 II, 5. 15. 6 | Chertkoff R, Zimran A (2006): National health budgets
388 II, 5. 15. 6 | model. Blood Cells Mol Dis. 2006 Jul-Aug;37(1):46-9. Epub
389 II, 5. 15. 6 | Jul-Aug;37(1):46-9. Epub 2006 Jul 7.~McCabe C, Claxton
390 II, 5. 15. 6 | orphan drugs. J Intern Med. 2006; 260(1):1-10.~ ~ ~
391 II, 6. 3. 3 | through the introduction in 2006 of a vaccine, but is not
392 II, 7. 1 | Communication from the Commission of 2006. In order to assist national
393 II, 7. 4. 1 | practice guide” (MacKay et al, 2006), and is providing materials
394 II, 7. 4. 5 | Community-wide (European Commission, 2006).~ ~Valuable information
395 II, 7. 4. 6 | area (European Commission, 2006).~ ~In the general school
396 II, 7. 4. 7 | society (European Commission, 2006).~ ~No single factor explains
397 II, 7. 5 | compare Shields et al, 2006). Other areas that are less
398 II, 7. 5 | safer Europe” from June 23, 2006, developed by DG Sanco together
399 II, 7. 5 | States (European Commission, 2006). The Communication informs
400 II, 7. 5 | the WHO (Schopper et al, 2006). This guideline conceptualises
401 II, 7. 7 | Freizeitunfallstatistik 2006. Vienna, Kuratorium für
402 II, 7. 7 | European Commission (2006): Communication from the
403 II, 7. 7 | for a safer Europe. COM/2006/0328 of June 23, 2006 (CELEX-Nr.
404 II, 7. 7 | COM/2006/0328 of June 23, 2006 (CELEX-Nr. 52006DC0328).~ ~
405 II, 7. 7 | J, Brussoni M, Towner L (2006): Child Safety Good Practice
406 II, 7. 7 | JD, Waxweiler R (Eds.) (2006): Developing policies to
407 II, 7. 7 | Aguirre I, Baumgarten I (2006): National responses to
408 II, 8. 1. 4 | developments~ ~EUROSTAT launched in 2006 a project, with the aim
409 II, 8. 1. 5(3) | Assembly on 13 of December 2006.~
410 II, 8. 1. 5 | phase of the Action Plan (2006-2007)6 focused on the active
411 II, 8. 2. 1 | following the Census of 2006, and preliminary results
412 II, 8. 2. 1 | two Interim Reports for 2006 and 2007 that can be found
413 II, 8. 2. 1 | and care. As Cooper et al (2006) note, regular health screening
414 II, 8. 2. 1 | Martin, G. and Robinson, N. (2006). Improving the health of
415 II, 8. 2. 1 | 121~Pezzementi and Fisher (2006). Oral health status of
416 II, 8. 2. 1 | 57:64-66.~Stegeman, I. (2006). Health Inequalities in
417 II, 8. 2. 2 | health-care systems. In May 2006, the World Health Assembly
418 II, 8. 2. 2 | BLINDNESS - ACTION PLAN 2006–2011” highlights the main
419 II, 8. 2. 2 | World Health Assembly in 2006.~ ~
420 II, 8. 2. 2 | avoidable blindness, action plan 2006 - 2011. Available online
421 II, 9 | et al, 1994; Reddy et al, 2006). Studies report higher
422 II, 9 | anomalies (Botto et al, 2006). Other nutrients are most
423 II, 9 | 2004; Macintosh et al, 2006), and there is increasing
424 II, 9 | of care (Macintosh et al, 2006). The rising prevalence
425 II, 9 | adulthood (Michels et al, 2006)~ ~Current EU environments
426 II, 9. 1. 1 | term babies (Escobar et al, 2006; Kramer et al, 2000a; Marret
427 II, 9. 1. 1 | decade (Langhoff-Ross et al, 2006); these trends, which cannot
428 II, 9. 1. 1 | M, Breart G, Zeitlin J (2006): Preterm birth and multiple
429 II, 9. 1. 1 | the PERISTAT project. Bjog 2006;113(5):528-35.~ ~Bouvier-Colle
430 II, 9. 1. 1 | GJ, Clark RH, Greene JD (2006): Short-term outcomes of
431 II, 9. 1. 1 | questions. Semin Perinatol 2006;30(1):28-33.~ ~EUROSTAT
432 II, 9. 1. 1 | EUROSTAT DATABASE. htt nd 2006;accessed January 2008.~ ~
433 II, 9. 1. 1 | B, Rasmussen S, Vogel I (2006): Spontaneous preterm delivery
434 II, 9. 1. 1 | population based study. Bmj 2006;332(7547):937-9.~ ~Lin HC,
435 II, 9. 1. 1 | UM, Ko CW, Willinger M (2006): Maternal age and the risk
436 II, 9. 1. 1 | States. Am J Obstet Gynecol 2006;195(3):764-70.~SCPE (Surveillance
437 II, 9. 1. 2 | exposures (Bianchi et al, 2006).~ ~
438 II, 9. 1. 2 | et al, 1994; Reddy et al, 2006). Studies report higher
439 II, 9. 1. 2 | anomalies (Botto et al, 2006). Other nutrients are most
440 II, 9. 1. 2 | 2004; Macintosh et al, 2006), and there is increasing
441 II, 9. 1. 2 | of care (Macintosh et al, 2006). The rising prevalence
442 II, 9. 1. 2 | anomalies also (Botto et al, 2006) by raising the folate status
443 II, 9. 1. 2 | Stoll C and Mastroiacovo P (2006): "Trends of Selected Malformations
444 II, 9. 1. 2 | Fleming KM, Bailey JA et al (2006): Perinatal mortality and
445 II, 9. 1. 2 | population-based study. BMJ. 2006 July 22; 333(7560): 177.~
446 II, 9. 2. 3 | 2003), although in November 2006 the UK Health Protection
447 II, 9. 2. 3 | 1996 to 3 000 in 2005) (HPA 2006). However, trends in fluctuation
448 II, 9. 2. 3 | Lobstein and Jackson-Leach, 2006)).~ ~The World Health Organisation
449 II, 9. 2. 3 | is so concerned that in 2006 it organised a conference
450 II, 9. 2. 6 | the Finnish Presidency in 2006 (Ståhl et al, 2006; Council
451 II, 9. 2. 6 | Presidency in 2006 (Ståhl et al, 2006; Council of the European
452 II, 9. 2. 6 | Council of the European Union, 2006), and through the Rome Ministerial
453 II, 9. 2. 7 | Council of the European Union (2006): Council Conclusions on
454 II, 9. 2. 7 | Network-UN Meeting Florence (2006): Promoting Healthy Lives
455 II, 9. 2. 7 | Rights of the Child” COM(2006) 367 final. Available at:~htt ~ ~
456 II, 9. 2. 7 | of Commitments. 29 March 2006. http://ec.europa.eu/health/
457 II, 9. 2. 7 | No. 246 p 13. 9 November, 2006~ ~European Commission (2007):
458 II, 9. 2. 7 | Protection Agency (HPA) (2006): A complex Picture – HIV
459 II, 9. 2. 7 | hpa.org.uk/publications/2006/hiv_sti_2006/pdf/keypoints_
460 II, 9. 2. 7 | publications/2006/hiv_sti_2006/pdf/keypoints_recommend.
461 II, 9. 2. 7 | Lahtinen E, Leppo K (eds.) (2006): Health in All Policies –
462 II, 9. 2. 7 | 12 September 2005~ ~WHO (2006) Regional Office for Europe:
463 II, 9. 3. 1 | in men (White & Holmes, 2006). Apart from very few male
464 II, 9. 3. 1 | country (White & Holmes, 2006). It can be argued that
465 II, 9. 3. 1 | females (Niederlaender, 2006). This greater risk of road
466 II, 9. 3. 1 | and Latvia (WHO HFA-DB, 2006).~ ~Mental health, psychiatric
467 II, 9. 3. 1 | behaviour and self harm (White, 2006). This is coupled with the
468 II, 9. 3. 1 | higher among women (EIWH, 2006). Depression is the main
469 II, 9. 3. 1 | testing and treatment (Arber, 2006).~ ~Because CVD tends to
470 II, 9. 3. 1 | European Heart Network, 2006). Hormonal balance associated
471 II, 9. 3. 1 | population) (White and Homes, 2006). A similar pattern was
472 II, 9. 3. 1 | vasculature (White and Holmes, 2006).~ ~The main circulatory
473 II, 9. 3. 1 | EU27 average (WHO HFA-DB, 2006).~ ~Stroke. Stroke is an
474 II, 9. 3. 1 | 24 years of age (EuroHIV, 2006). In many societies, it
475 II, 9. 3. 1 | Slovenia and the UK (WHO, 2006). In November 2006, the
476 II, 9. 3. 1 | WHO, 2006). In November 2006, the UK Health Protection
477 II, 9. 3. 1 | 1996 to 3 000 in 2005 (HPA, 2006). Trends in fluctuation
478 II, 9. 3. 1 | Clinical Practice Guidelines (2006) suggest a repeated level <
479 II, 9. 3. 1 | adulthood (Michels et al, 2006)~ ~Current EU environments
480 II, 9. 3. 1 | McKinlay J, Adams A, et al, (2006): Patient characteristics
481 II, 9. 3. 1 | European Commission.~ ~EuroHIV (2006) : HIV/AIDS Surveillance
482 II, 9. 3. 1 | Luxembourg~ ~European Commission (2006): Report on Equality between
483 II, 9. 3. 1 | figures: Eurostat yearbook 2006-07. Luxembourg: Office for
484 II, 9. 3. 1 | Publishing, Oxford.~ ~HPA (2006): ht m (Article online,accessed
485 II, 9. 3. 1 | Equality Policy. Helsinki (2006): 112 pp. (Publications
486 II, 9. 3. 1 | Terry KL and Willett WC (2006): Longitudinal Study on
487 II, 9. 3. 1 | 1992Impotence091html.htm~ ~Niederlaender E (2006): Causes of death in the
488 II, 9. 3. 1 | And Social Conditions 10/2006~ ~Plümper T, Neumayer E (
489 II, 9. 3. 1 | Plümper T, Neumayer E (2006): The unequal burden of
490 II, 9. 3. 1 | 57(1):48-52.~ ~White AK (2006): Men and mental wellbeing:
491 II, 9. 3. 1 | 7~ ~White AK, Holmes M, (2006): Patterns of mortality
492 II, 9. 3. 1 | epidemic http / (accessed April 2006)~ ~WHO (2006): European
493 II, 9. 3. 1 | accessed April 2006)~ ~WHO (2006): European Charter on counteracting
494 II, 9. 3. 1 | counteracting obesity November 2006 http 1 (Article online,
495 II, 9. 3. 1 | accessed 07.07)~ ~WHO (2006): European Ministerial Conference
496 II, 9. 3. 1 | Counteracting Obesity: November 2006 http f (Article online,
497 II, 9. 3. 1 | accessed 07.07)~ ~WHO HFA-DB (2006): Health for All Database: htt / (
498 II, 9. 3. 2 | France (Philibert et al, 2006) or the Netherlands (van
499 II, 9. 3. 2 | EUGLOREH countries in 2004-2006~ ~For a few countries -
500 II, 9. 3. 2 | post-term births (Blondel et al, 2006; Zeitlin et al, 2007). Similarly,
|
|
| |
